Plasma level of a triggering receptor expressed on myeloid cells-1: Its diagnostic accuracy in patients with suspected sepsis

Annals of Internal Medicine

Volumn 141, Issue 1, 2004, Pages

  Gibot, Sébastien ^a   Kolopp Sarda, Marie Nathalie ^b   Béné, Marie C ^b   Cravoisy, Aurélie ^b   Levy, Bruno ^b   Faure, Gilbert C ^b   Bollaert, Pierre Edouard ^b  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; PROTEIN TREM 1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CRITICAL ILLNESS; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; SEPSIS;

EID: 3042818432     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-141-1-200407060-00009     Document Type: Article

References (25)

1. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-50. [PMID: 12519925]
2. Reinhart K, Meisner M, Hartog C. Diagnosis of sepsis: novel and conventional parameters. Advances in Sepsis. 2001;2:42-8.
3. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA. 1995;273:117-23. [PMID: 7799491]
4. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med. 2000;26 Suppl 1:S64-74. [PMID: 10786961]
5. Birmingham MC, Hassett JM, Schentag JJ, Paladino JA. Assessing antibacterial pharmacoeconomics in the intensive care unit. Pharmacoeconomics. 1997;12:637-47. [PMID: 10175976]
6. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341:515-8. [PMID: 8094770]
7. Vincent JL. Procalcitonin: THE marker of sepsis? [Editorial]. Crit Care Med. 2000;28:1226-8. [PMID: 10809314]
8. Brunkhorst FM, Wegscheider K, Forycki ZF, Brunkhorst R. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med. 2000;26:S148-52.
9. Lapillonne A, Basson E, Monneret G, Bienvenu J, Salle BL. Lack of specificity of procalcitonin for sepsis diagnosis in premature infants [Letter]. Lancet. 1998;351:1211-2. [PMID: 9643726]
10. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL. Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med. 1999;27:498-504. [PMID: 10199528]
11. Ruokonen E, Nousiainen T, Pulkki K, Takala J. Procalcitonin concentrations in patients with neutropenic fever. Eur J Clin Microbiol Infect Dis. 1999;18:283-5. [PMID: 10385017]
12. Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol. 2000;164:4991-5. [PMID: 10799849]
13. Bouchon A, Facchetti F, Weigand MA, Colonna M. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature. 2001;410:1103-7. [PMID: 11323674]
14. Gibot S, Cravoisy A, Levy B, Bene MC, Faure G, Bollaert PE. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med. 2004;350:451-8. [PMID: 14749453]
15. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101:1644-55. [PMID: 1303622]
16. McCabe WR, Jackson GG. Gram-negative bacteremia. Arch Intern Med. 1962;110:847-64.
17. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957-63. [PMID: 8254858]
18. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-10. [PMID: 8844239]
19. Fischer JE, Bachmann LM, Jaeschke R. A readers' guide to the interpretation of diagnostic test properties: clinical example of sepsis. Intensive Care Med. 2003;29:1043-51. [PMID: 12734652]
20. Bates DW, Cook EF, Goldman L, Lee TH. Predicting bacteremia in hospitalized patients. A prospectively validated model. Ann Intern Med. 1990;113:495-500. [PMID: 2393205]
21. Boucher BA, Hanes SD. Searching for simple outcome markers in sepsis: an effort in futility? [Editorial] Crit Care Med. 1999;27:1390-1. [PMID: 10446842]
22. Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M, et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol. 2003;170:3812-8. [PMID: 12646648]
23. Colonna M. TREMs in the immune system and beyond. Nat Rev Immunol. 2003;3:445-53. [PMID: 12776204]
24. Cohen J. TREM-1 in sepsis. Lancet. 2001;358:776-8. [PMID: 11564478]
25. Nathan C, Ding A. TREM-1: a new regulator of innate immunity in sepsis syndrome. Nat Med. 2001;7:530-2. [PMID: 11329047]